| IVP 0.082 256.52% | OCG 0.0118 4.42% | SOXS 2.28 0.48% | SEGG 0.9267 79.91% | ZSL 2.82 -14.80% | MTEN 0.0353 4.75% | SLV 84.56 7.58% | SAFX 0.1373 -17.74% | NVDA 183.14 -1.44% | INTC 48.72 3.02% | ASST 1.03 6.19% | TZA 6.16 -1.99% | TQQQ 53.83 -3.18% | JTAI 0.4546 13.65% | DVLT 0.7182 -10.33% | SPY 690.36 -0.49% | PSTV 0.2904 -38.23% | BBAI 6.26 2.79% | IBIT 55.44 3.49% | ONDS 13.56 -2.38% | MSTX 5.2 7.22% | PLUG 2.35 3.07% | ROLR 18.89 436.65% | XLE 48.06 2.26% | QQQ 619.55 -1.07% | TSLL 18.07 -3.58% | BAC 52.48 -3.78% | SOXL 55.38 -1.23% | ASBP 0.0587 -26.44% | BMNR 32.68 4.68% | BITO 13.56 3.39% | TSLS 5.19 1.76% | DUST 5.8 -0.68% | AAL 15.14 -1.37% | BITF 2.94 -5.47% | FNGD 5.51 5.15% | DNN 3.49 4.33% | ACHR 8.91 5.19% | CLSK 13.34 6.29% | F 13.835 -1.04% | JDST 2.11 -0.71% | XLF 54.15 -0.15% | CRML 17.925 32.58% | BEEM 1.87 5.65% | ETHA 25.59 5.66% | TSLA 439.2 -1.79% | OPEN 6.64 -1.92% | MARA 11.11 1.46% | PBR 12.66 2.93% | SIDU 3.75 20.58%

Recent Market Trends Highlight Top Gainers

In recent market trends, several companies have emerged as top gainers, showcasing significant price movements and trading volumes. AMTD Digital Inc. (NYSE:HKD) leads with a 93.49% price increase to $3.27, driven by a trading volume of approximately 286.36 million. This surge is supported by a remarkable 1,085.9% revenue increase for the six months ending April 30, 2025, following the consolidation of The Generation Essentials Group as a subsidiary since October 2024, as highlighted by the company.

Beneficient (NASDAQ:BENF) experienced a 57.18% increase in its stock price to $0.87, with a trading volume of over 113.62 million. The company has regained compliance with Nasdaq's periodic filing and market value requirements, which may have contributed to the heightened investor interest. However, Beneficient still needs to address the $1.00 per share bid price requirement to avoid delisting.

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) saw a 50.69% increase in its stock price to $2.18, with a trading volume of over 31.48 million. The company is set to present preclinical data on its innovative RaniPill® capsule at ObesityWeek® 2025, which may have fueled investor interest in its innovative healthcare solutions.

YD Bio Limited Warrants (YDESW) experienced a 47.06% increase in its stock price to $1.5, despite a smaller trading volume of 22,699. The company's focus on detection and therapeutic technologies has shown promising growth potential, attracting investor attention.

These movements reflect a dynamic market environment, with investors showing keen interest in companies across various sectors. The significant price changes and trading volumes highlight the market's responsiveness to company developments, investor sentiment, and broader economic factors.

Published on: October 31, 2025